News | Analytics Software | February 01, 2017

Almost Three-quarters of Healthcare Companies Will Invest in Big Data by 2021

New business intelligence cites technological advancements and declining costs as major drivers, stresses importance of adoption

big data, GBI Research, 2021, healthcare companies, Arshad Ahad

Big data showing a CDC versus Twitter study of cardiovascular disease predictions from an American College of Cardiology (ACC) slide.

February 1, 2017 — As the useful applications of big data in the pharmaceutical and healthcare sector become increasingly apparent, 73 percent of organizations in the industry are set to begin or increase investment in big data within the next five years, according to business intelligence provider GBI Research.

The company’s latest report states that there are a number of factors promoting the use of big data in healthcare. Arshad Ahad, analyst for GBI Research, explained: “Advances in technology have led to an explosion in healthcare-related data generation. This data represents an invaluable resource, which can bring many commercial benefits to organizations if properly utilized and acted upon, although the fundamental properties of big data – its volume, velocity and variability – make this a challenging prospect”.

The advancement in technologies and a commensurate decline in costs of genome sequencing, for example, have increased the rate of biological data generation at an exponential rate, evidenced by data from the National Human Genome Research Institute. As costs fall further, it may be feasible in the near future to store genomic data for large subsets of patients, or even every patient. This would represent a huge technical challenge, but the analytical benefits it could provide are enormous.

The commercial benefits big data can provide are incentivizing pharmaceutical and healthcare companies to embrace the technology. Mining data in conjunction with predictive modeling, for example, could be used to identify new drug candidates with a greater likelihood of success.

Big data could also be used to overhaul clinical trial processes, making them more powerful, shorter and less expensive. Other uses of this data include using the technology to detect waste and inappropriate use of resources, aid in the development of personalized therapies, implement value-based healthcare and collect real-world evidence.

Ahad continued: “Big data is no longer an abstract concept that could provide benefits in the future. It exists now and is already providing competitive advantages for a variety of organizations. As such, companies which ignore its potential risk falling behind their peers in our increasingly data-intensive world.”

For more information: www.gbiresearch.com

Related Content

ScImage Awarded U.S. Government DIN-PACS IV Contract
News | PACS| August 16, 2017
ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications...
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Xavier University Announces Healthcare Artificial Intelligence Summit
News | Artificial Intelligence| August 07, 2017
Xavier University has launched the Xavier Center for Artificial Intelligence (AI), a pioneering effort to accelerate...
Nuance Restores Service to Majority of eScription Clients Following Malware Incident
News | Information Technology| July 28, 2017
Nuance Communications Inc. provided an update on its restoration process following the previously reported June 27,...
The Centricity Cardio Enterprise (CCE) Interactive Guide offers information on GE's cardiovascular information system (CVIS)
News | Cardiac PACS| July 28, 2017
July 28, 2017 — GE Healthcare has released the eight-page...
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
WVU Medicine Deploys Enterprise PACS from ScImage
News | Cardiac PACS| July 24, 2017
ScImage Inc. recently announced West Virginia University Health System has partnered with ScImage to utilize ScImage’s...
TomTec Unveils TomTec Zero Cardiovascular Viewing Software
Technology | Remote Viewing Systems| July 24, 2017
TomTec Zero is the latest addition to the TomTec portfolio. Now every physician reading cardiovascular studies at...
CareSelect Declared Fully Qualified Clinical Decision Support Mechanism by CMS
News | Clinical Decision Support| July 18, 2017
National Decision Support Company announced the full qualification of its CareSelect Platform as a Qualified Clinical...
CMS Proposes Delaying Clinical Decision Support Documentation to 2019
News | Clinical Decision Support| July 14, 2017 | Jeff Zagoudis, Associate Editor
In a series of proposed rule changes to the Medicare Physician Fee Schedule (MPFS) released July 13, the Centers for...
Overlay Init